How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

552 results for

Famciclovir

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

-viral drug. Subject has had an infection with HSV-1 isolates know to be resistant to acyclovir, valacyclovir, famciclovir, or ganciclovir. Subject has had a herpes vaccine. Females during pregnancy, lactation or breastfeeding. Subject has a history of alcoholism or drug abuse within the preceding 12 months. Subject is currently enrolled in another clinical trial involving the use of a drug and/or a device. Any history which, in the Investigator's judgment, makes the subject ineligible or places

2015 Clinical Trials

102. Treatment of herpes zoster with ultrasound-guided superficial cervical plexus block (PubMed)

Treatment of herpes zoster with ultrasound-guided superficial cervical plexus block Herpes zoster most commonly occurs in elderly patients, and usually affects sensory neurons. Therefore, its characteristic symptoms are segmental pain, itching, and sensory changes in the affected areas. A 71-yr-old woman experienced painful herpetic rash on the right cervical 2-4 dermatomes for 16 days. Two days after the onset of the rash, she was diagnosed with herpes zoster, and prescribed 250 mg famciclovir

Full Text available with Trip Pro

2015 Journal of Dental Anesthesia and Pain Medicine

103. Postherpetic Wolf's isotopic response: Possible contribution of resident memory T cells to the pathogenesis of lichenoid reaction. (PubMed)

, Tokyo, 160-8582, Japan. Ohyama M M Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. eng Case Reports Letter 2015 10 16 England Br J Dermatol 0004041 0007-0963 0 Antigens, CD 0 Antigens, Differentiation, T-Lymphocyte 0 Antiviral Agents 0 CD69 antigen 0 Lectins, C-Type 452-06-2 2-Aminopurine QIC03ANI02 Famciclovir IM 2-Aminopurine administration & dosage analogs & derivatives Antigens, CD immunology Antigens, Differentiation, T (...) -Lymphocyte immunology Antiviral Agents administration & dosage Famciclovir Herpes Zoster drug therapy immunology pathology Humans Immunologic Memory immunology Lectins, C-Type immunology Lichenoid Eruptions etiology immunology pathology Male Middle Aged Recurrence T-Lymphocytes immunology 2015 6 27 6 0 2015 6 27 6 0 2016 10 19 6 0 ppublish 26114399 10.1111/bjd.13968

2015 British Journal of Dermatology

104. MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

allogeneic HSCT (previous autologous HSCT is acceptable) History of CMV end-organ disease within 6 months before randomization Has evidence of CMV viremia (if tested) at any time from either signing of the Informed Consent Form or the HSCT procedure, whichever is earlier, until the time of randomization. Received the following within 7 days before screening or plans to receive during the study: ganciclovir, valganciclovir, foscarnet, acyclovir, valacyclovir, or famciclovir Received the following within

2014 Clinical Trials

105. Brain Inflammation and Function in Alcoholism

that are systemic corticosteroids; antibiotics; anticholinergics; anticoagulants; anticonvulsants; antidepressants; antidiarrheal preparations; antifungal agents (systemic); antihistamines (sedating); antihypertensives; anti-inflammatory drugs (systemic); antineoplastics; antiobesity; antipsychotics; antivirals (except for treatment of HSV with agents without CNS activity, e.g. acyclovir, ganciclovir, famciclovir, valacyclovir); anxiolytics; cough/cold preparations (dextromethorphan preparations

2014 Clinical Trials

106. Dopamine Rhythms in Health and Addiction

); antianginal agents; antiarrhythmics; antiasthma agents that are systemic corticosteroids; antibiotics; anticholinergics; anticoagulants; anticonvulsants; antidepressants; antidiarrheal preparations; antifungal agents (systemic); antihistamines (sedating); antihypertensives; anti-inflammatory drugs (systemic); antineoplastics; antiobesity; antipsychotics; antivirals (except for treatment of HSV with agents without CNS activity, e.g. acyclovir, ganciclovir, famciclovir, valacyclovir); anxiolytics

2014 Clinical Trials

107. Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

from samples collected within 14 days prior to enrollment. Local assays could be used to qualify the patient for enrollment. Received any of the following within 30 days prior to enrollment: ganciclovir, valganciclovir, foscarnet, cidofovir, acyclovir (>25 mg/kg/day IV), valacyclovir (>3 gm/day oral), famciclovir (>1500 mg/day oral), HCMV immune globulin, immune globulin (>500 mg/kg), or any other medication with anti-HCMV activity. Required mechanical ventilation within 7 days prior to enrollment

2014 Clinical Trials

108. Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

by concordant rapid testing HSV-2 seropositive (Focus HerpeSelect EIA >3.4) At least one prior occurrence of GUD 18 to 50 years of age Exclusion Criteria: Current use, or use within the past 7 days, of acyclovir, valacyclovir, or famciclovir Prior hypersensitivity and/or allergic reaction to acyclovir Use of probenecid, which prolongs renal excretion of acyclovir Current use, or use within the past 28 days, of an investigational agent Currently pregnant or nursing Currently plan to become pregnant during

2014 Clinical Trials

109. Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

treatment (approved or investigational) at any time before screening Patient has a medical condition that requires frequent use of systemic acyclovir or famciclovir, systemic corticosteroids, potentially hepatotoxic drugs or nephrotoxic drugs or chemotherapy Patient has one or more additional known primary or secondary causes of liver disease, other than CHB; has a decompensated liver disease ; is a Liver transplant recipient or organ or bone marrow transplant recipient. History of any other acute

2014 Clinical Trials

110. Genetically Engineered HSV-1 Phase 1 Study

ganglia, or posterior fossa inoculation or would require access through a ventricle in order to deliver treatment. Prior history of encephalitis, multiple sclerosis, or other CNS infection. Required steroid increase within 2 weeks of scheduled M032 administration. Active oral herpes lesion. Concurrent therapy with any drug active against HSV (acyclovir, valacyclovir, penciclovir, famciclovir, gancyclovir, foscarnet, cidofovir). Uncontrolled intercurrent illness including, but not limited to ongoing

2014 Clinical Trials

112. Postherpetic Neuralgia (Overview)

for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA . 1998 Dec 2. 280(21):1837-42. . Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol . 1995 Feb. 37(2):246-53. . Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med

2014 eMedicine.com

114. Esophagitis (Overview)

complications Treatment of reflux esophagitis may include the following: Histamine-2 receptor antagonists (H2RAs) Proton pump inhibitors (PPIs) Cisapride (a gastroprokinetic agent) Sucralfate (a coating agent) Treatment of infectious esophagitis is directed at the underlying cause, as follows: Fungal esophagitis – Topical, oral, or parenteral antifungals HSV esophagitis – Acyclovir, foscarnet (for acyclovir-resistant cases), or famciclovir CMV esophagitis – Ganciclovir and foscarnet HIV esophagitis – Oral (...) corticosteroids in conjunction with antiretroviral therapy Varicella-zoster virus (VZV) esophagitis – Acyclovir, famciclovir, or foscarnet (for acyclovir-resistant cases) Epstein-Barr virus (EBV) esophagitis – Acyclovir Human papillomavirus (HPV) esophagitis – No treatment, in most cases; systemic interferon alfa, bleomycin, or etoposide Tuberculous esophagitis – Standard antituberculous therapy Bacterial esophagitis – Broad-spectrum beta-lactam antibiotics, usually with an aminoglycoside, adjusted

2014 eMedicine.com

115. Acute Retinal Necrosis (Follow-up)

acyclovir, valacyclovir, ganciclovir, famciclovir, and foscarnet. An anti-inflammatory, such as prednisone, should be started 24-48 hours after antiviral therapy is initiated. Antiplatelets (aspirin) should be started 24-48 hours after beginning antiviral therapy. Previous Next: Deterrence/Prevention Prophylactic barrier laser to the peripheral retina posterior to the areas of retinal necrosis is required to reduce the risk of retinal detachment. Previous Next: Complications Complications of acute

2014 eMedicine.com

116. Benign Cervical Lesions (Follow-up)

Azithromycin 1 g PO or Doxycycline 100 mg PO bid for 7 d Erythromycin base 500 mg PO qid for 7 d or Erythromycin ethylsuccinate 800 mg PO qid for 7 d N gonorrhoeae Cefixime 400 mg PO or Ceftriaxone 125 mg IM or Azithromycin 1 g PO or Doxycycline 100 mg PO bid for 7 d Spectinomycin 2 g IM or Ceftizoxime 500 mg IM or Cefotaxime 500 mg IM or Cefotetan 1 g IM or Cefoxitin 2 g + probenecid 1 g PO HSV Acyclovir 400 mg PO tid for 7-10 d or Acyclovir 200 mg PO 5 times/d for 7-10 d or Famciclovir 250 mg PO tid (...) or Acyclovir 200 mg PO 5 times/d for 7-10 d or Famciclovir 250 mg PO tid for 7-10 d or Valacyclovir 1 g PO bid for 7-10 d T vaginalis Metronidazole 2 g PO or Metronidazole 500 mg bid for 7 d Contributor Information and Disclosures Author Khanh-Ha D Nguyen, MD, MPH Clinical Fellow in Medical Genetics, National Human Genome Research Institute, National Institutes of Health Khanh-Ha D Nguyen, MD, MPH is a member of the following medical societies: , , , Disclosure: Nothing to disclose. Specialty Editor Board

2014 eMedicine.com

117. Skin Resurfacing, Laser: Erbium YAG

. Erbium:YAG laser resurfacing of the hands, arms, and neck. Dermatol Surg . 1999 Nov. 25(11):831-4; discussion 834-5. . Kaufmann R. Role of Erbium:YAG laser in the treatment of aged skin. Clin Exp Dermatol . 2001 Oct. 26(7):631-6. . Monheit GD. Facial resurfacing may trigger the herpes simplex virus. Cosmet Derm . 1995. 8:9-16. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg . 1999 Mar. 25(3):242-6. . West TB, Alster TS. Effect

2014 eMedicine Surgery

119. Cutaneous Laser Resurfacing: Erbium:YAG (Follow-up)

to reactivation of latent herpes simplex virus infection or predispose the patient to a primary infection during the reepithelialization phase of healing. It is recommended that prophylactic antiviral medication be prescribed during the postoperative period, regardless of a patient's herpes simplex virus history. Commonly used regimens include famciclovir 250 mg twice daily, acyclovir 400 mg 3 times a day, or valacyclovir 500 mg twice daily. The medication may be administered the day before, or morning

2014 eMedicine.com

120. Cutaneous Laser Resurfacing: Carbon Dioxide (Follow-up)

are recommended to routinely prescribe the prophylactic use of an antiviral medication during the postoperative period, regardless of a patient's herpes simplex virus history. Some surgeons begin the regimen 24 h prior to surgery, while others initiate treatment on the morning of surgery. Commonly used regimens include famciclovir 250 mg PO bid, acyclovir 400 mg PO tid, and valacyclovir 500 mg PO bid for 7-10 d. Antibiotics Some surgeons routinely prescribe antibiotics for bacterial prophylaxis; however

2014 eMedicine.com

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>